forty-six patients with recalcitrant rheumatoid arthritis entered a trial encompassing a 2-week inpatient period plus a 16-week , randomized double blind , parallel study comparing placebo , 5 mg/m2 and 10 mg/m2 oral weekly methotrexate ( mtx ) .
C0003873
rheumatoid arthritis
C0025677
methotrexate